Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

View source ↗

Summary

This entry notes the completion of a clinical trial evaluating the safety and tolerability of lenvatinib in participants with advanced or unresectable hepatocel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Carcinoma, Hepatocellular | Status: COMPLETED